Relight Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Relight Phase. Real-time updates on events, politics, business and more.

Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results

November 9, 2023

Progress in Clinical Development and Financial Highlights

Sergio Traversa Relmada Therapeutics Inc Therapeutics Inc Relight Phase Clinical Development Ash And Cash Equivalents

Source: yahoo.com

Relmada Therapeutics Announces Dosing of First Patient in Relight, a Phase 3 Trial of REL-1017 for the Adjunctive Treatment of Major Depressive Disorder

August 23, 2023

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Cedric Ogorman Tim Mccarthy Relmada Therapeutics Inc Prnewswire Relmada Therapeutics Inc Clinical Research Program Securities Exchange

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Relight Phase News Today

Relmada Therapeutics Inc (RLMD) Reports Third Quarter 2023 Financial Results

Relmada Therapeutics Announces Dosing of First Patient in Relight, a Phase 3 Trial of REL-1017 for the Adjunctive Treatment of Major Depressive Disorder

Explore More Categories